India to Belarus: Erlotinib Export Trade Route
India has recorded 4 verified shipments of Erlotinib exported to Belarus, representing a combined trade value of $106.0K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $26.5K USD. The leading Indian exporter is LOTUSPHARM MANUFACTURING PRIVATE LIMITED, which accounts for 88% of total export value with 2 shipments worth $93.2K USD. On the buying side, BELPHARMACIA RUE is the largest importer in Belarus with $93.2K USD in purchases. The top 3 suppliers — LOTUSPHARM MANUFACTURING PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED , HETERO LABS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Belarus Erlotinib corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $106.0K USD. The route is dominated by LOTUSPHARM MANUFACTURING PRIVATE LIMITED, which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $26.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with erlotinib's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 28.8%, placing it at rank #17 among India's top erlotinib export destinations globally.
On the import side, key buyers of Indian erlotinib in Belarus include BELPHARMACIA RUE, TISHAS ADDITIONAL LIABILITY COMPANY , TO THE ORDER OF. BELPHARMACIA RUE is the single largest importer with 2 shipments valued at $93.2K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#17
- Annual growth+28.8%
- Demand growth+25.9%
- Regulatory ease88/100
Top 10 Indian Erlotinib Exporters to Belarus
Showing top 10 of 3 Indian suppliers exporting Erlotinib to Belarus, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LOTUSPHARM MANUFACTURING PRIVATE LIMITED Avg $46.6K per shipment | 2 | $93.2K | 87.9% |
| 2 | SP ACCURE LABS PRIVATE LIMITED Avg $12.8K per shipment | 1 | $12.8K | 12.0% |
| 3 | HETERO LABS LIMITED Avg $48 per shipment | 1 | $48 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting erlotinib to Belarus, ranked by total trade value. The listed exporters are: LOTUSPHARM MANUFACTURING PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED , HETERO LABS LIMITED. LOTUSPHARM MANUFACTURING PRIVATE LIMITED is the dominant supplier with 2 shipments worth $93.2K USD, giving it a 88% market share.
Top 10 Erlotinib Importers in Belarus
Showing top 10 of 3 known buyers in Belarus receiving Erlotinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian erlotinib in Belarus include BELPHARMACIA RUE, TISHAS ADDITIONAL LIABILITY COMPANY , TO THE ORDER OF. The largest importer is BELPHARMACIA RUE, accounting for $93.2K USD across 2 shipments — representing 88% of all erlotinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BELPHARMACIA RUE | 2 | $93.2K | 87.9% |
| 2 | TISHAS ADDITIONAL LIABILITY COMPANY | 1 | $12.8K | 12.0% |
| 3 | TO THE ORDER OF | 1 | $48 | 0.0% |
Top 10 Erlotinib Formulations Imported by Belarus
Showing top 10 of 4 product formulations shipped on the India to Belarus Erlotinib route, ranked by trade value
Belarus imports a wide range of erlotinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ERLOTINIB 150MG TABLETS COATED (PACK SIZE.3X10S)[1229X30S=36870 NOS] — accounts for $47.3K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ERLOTINIB 150MG TABLETS COATED (PACK SIZE.3X10S)[1229X30S=36870 NOS] | 1 | $47.3K | 44.6% |
| 2 | ERLOTINIB 150MG TABLETSCOATED (PACK SIZE.3 X 10S)[1181 X 30 S = 35430 NOS] | 1 | $45.9K | 43.3% |
| 3 | TARCESP 150 (ERLOTINIB FILM-COATED TABLE | 1 | $12.8K | 12.0% |
| 4 | ERLOTINIB HYDROCHLORIDE WS (ALONG WITHAS PER INVOICE) | 1 | $48 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 2 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's erlotinib exports to Belarus are driven primarily by a handful of large-scale manufacturers. LOTUSPHARM MANUFACTURING PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Belarus benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LOTUSPHARM MANUFACTURING PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED , HETERO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $26.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as erlotinib 150mg tabletscoated (pack size.3 x 10s)[1181 x 30 s = 35430 nos] and tarcesp 150 (erlotinib film-coated table , suggesting that buyers in Belarus tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BELPHARMACIA RUE is the largest importer with 2 shipments worth $93.2K USD — representing 88% of all erlotinib imports from India on this route.
Route Statistics
- Trade Volume
- $106.0K
- Avg. Shipment
- $26.5K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~16 days
- Annual Growth
- +28.8%
Other Erlotinib Routes
Unlock the Full India to Belarus Erlotinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to Belarus Erlotinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Erlotinib to Belarus?
The leading Indian exporters of Erlotinib to Belarus are LOTUSPHARM MANUFACTURING PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED , HETERO LABS LIMITED. LOTUSPHARM MANUFACTURING PRIVATE LIMITED holds the largest market share at approximately 88% of total trade value on this route.
Q What is the total value of Erlotinib exports from India to Belarus?
India exports Erlotinib to Belarus worth approximately $106.0K USD across 4 recorded shipments. The average value per shipment is $26.5K USD.
Q Which ports does India use to ship Erlotinib to Belarus?
The most active port of origin is HYDERABAD AIR with 2 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Belarus for Erlotinib?
The average transit time for Erlotinib shipments from India to Belarus is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Belarus Erlotinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.8% with demand growth tracking at 25.9%. The route is ranked #17 among India's top Erlotinib export destinations globally.
Q How many suppliers are active on the India to Belarus Erlotinib route?
There are currently 3 active Indian suppliers exporting Erlotinib to Belarus. The market is moderately concentrated with LOTUSPHARM MANUFACTURING PRIVATE LIMITED accounting for 88% of total shipment value.
Q Who are the main importers of Erlotinib from India in Belarus?
The leading importers of Indian Erlotinib in Belarus include BELPHARMACIA RUE, TISHAS ADDITIONAL LIABILITY COMPANY , TO THE ORDER OF. BELPHARMACIA RUE is the largest buyer with 2 shipments worth $93.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Belarus export trade corridor identified from Indian Customs (DGFT) records for Erlotinib.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Belarus matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists